(1R,4S,5S,8R)-8-[(Z)-2-[2,4-Bis(Trifluoromethyl)Phenyl]Ethenyl]-4,8-Dimethyl-6,7-Dioxabicyclo[3.3.1]Nonan-3-One
CAS: 123407-36-3
Ref. 3D-FB103024
Undefined size | To inquire |
Product Information
- (1S,4R,5R,8S)-4-((Z)-2,4-Bis(trifluoromethyl)styryl)-4,8-dimethyl-2,3-dioxabicyclo(3.3.1)nonan-7-one
- (1S,4R,5R,8S)-4-[(1Z)-2-[2,4-Bis(trifluoromethyl)phenyl]ethenyl]-4,8-dimethyl-2,3-dioxabicyclo[3.3.1]nonan-7-one
- (1S,4R,5R,8S)-4-{(Z)-2-[2,4-bis(trifluoromethyl)phenyl]ethenyl}-4,8-dimethyl-2,3-dioxabicyclo[3.3.1]nonan-7-one
- 2,3-Dioxabicyclo(3.3.1)nonan-7-one, 4-(2-(2,4-bis(trifluoromethyl)phenyl)ethenyl)-4,8-dimethyl-(1S-(1alpha,4beta(Z),5alpha,8beta))-
- 2,3-Dioxabicyclo[3.3.1]nonan-7-one, 4-[(1Z)-2-[2,4-bis(trifluoromethyl)phenyl]ethenyl]-4,8-dimethyl-, (1S,4R,5R,8S)-
- 2,3-Dioxabicyclo[3.3.1]nonan-7-one, 4-[2-[2,4-bis(trifluoromethyl)phenyl]ethenyl]-4,8-dimethyl-, [1S-[1α,4β(Z),5α,8β]]-
- Arteflene [USAN:INN]
- Ro 42-1611
- Unii-5Pe5Hv9Nf0
- Arteflene
- See more synonyms
(1R,4S,5S,8R)-8-[(Z)-2-[2,4-Bis(Trifluoromethyl)Phenyl]Ethenyl]-4,8-Dimethyl-6,7-Dioxabicyclo[3.3.1]Nonan-3-One is a sesquiterpene lactone that has been shown to have anti-cancer effects against human liver cancer cells. This compound is an analog of the natural product artemisinin and is structurally similar to the herb Artemisia annua L. It has been shown to inhibit cell growth in vitro and in vivo by binding to the p450 enzymes in the liver and blocking their activity. The low bioavailability of this compound is due to its high degree of chemical structure complexity which inhibits absorption from the gut. (1R,4S,5S,8R)-8-[(Z)-2-[2,
Chemical properties
Technical inquiry about: 3D-FB103024 (1R,4S,5S,8R)-8-[(Z)-2-[2,4-Bis(Trifluoromethyl)Phenyl]Ethenyl]-4,8-Dimethyl-6,7-Dioxabicyclo[3.3.1]Nonan-3-One
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.